MUMBAI, India, Nov. 7 -- Intellectual Property India has published a patent application (202517044687 A) filed by Yifan Biotechnology (SHANGHAI) Co. Ltd., Shanghai, on May 8, for 'crystal form of aclonifen and preparation method and use of crystal form.'
Inventor(s) include Wang, Pandeng; Wu, Haiqin; Wu, Kechong; Jia, Junchao; Guo, Kaijie; and Wang, Jia.
The application for the patent was published on Nov. 7, under issue no. 45/2025.
According to the abstract released by the Intellectual Property India: "The present invention discloses a crystal form of aclonifen, and a preparation method therefor and the use thereof. In the present invention, a crystal form of aclonifen is obtained by recrystallizing amorphous aclonifen, and is referred as solid form A of aclonifen. In the present invention, the crystal is analyzed by means of various analytical methods, and solid form A of aclonifen is used to prepare a stable agrochemical formulation. The preparation method for solid form A of aclonifen provided by the present invention has a high recovery rate, is simple and convenient, and can be scaled up. Moreover, the crystal form, i.e., solid form A of aclonifen, is highly stable when used for formulation of a preparation, and thus has good application prospects."
The patent application was internationally filed on Apr. 16, 2024, under International application No.PCT/CN2024/087918.
Disclaimer: Curated by HT Syndication.
